Current status and perspectives in the surgical and oncological management of intrahepatic cholangiocarcinoma

被引:2
|
作者
Dhote, Alix [1 ,2 ]
Tzedakis, Stylianos [1 ,3 ]
Shapira, Ortal Itzaki [1 ]
Nassar, Alexandra [1 ,3 ]
Boudjema, Karim [4 ]
Fuks, David [1 ,3 ,5 ]
机构
[1] Cochin Port Royal Hosp Grp, AP HP, Digest Hepatobiliary & Endocrine Surg Dept, DMU Cancerol & Med Surg Specialties, Paris, France
[2] Paris Sorbonne Univ, Paris, France
[3] Paris Cite Univ, Paris, France
[4] Rennes 1 Univ, Pontchaillou Hosp, Hepatobiliary & Digest Surg Dept, Rennes, France
[5] Univ Paris Cite, Hop Cochin, Serv Chirurg Digest Hepatobiliaire & Endocrinienne, Paris, France
关键词
Intrahepatic cholangiocarcinoma; Hepatectomy; Chemotherapy; Radio-embolization; neoadjuvant treatment; immunotherapy; PORTAL-VEIN EMBOLIZATION; LAPAROSCOPIC LIVER RESECTION; OPEN-LABEL; RADIATION-THERAPY; CHEMOTHERAPY; MULTICENTER; GEMCITABINE; TRANSPLANTATION; REGENERATION; CISPLATIN;
D O I
10.1016/j.jviscsurg.2023.07.007
中图分类号
R61 [外科手术学];
学科分类号
摘要
=Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor after hepatocellular carcinoma (HCC). Management depends on their resectability at the time of diagnosis. Two types can be distinguished by imaging: resectable ICCs amenable to surgery and locally advanced and/or metastatic ICCs, that are treated by chemotherapy, radiotherapy or loco-regional treatment (radioembolization, chemoembolization, intra-arterial chemotherapy and thermoablation). Over the last decade, the management strategy for these tumors has been modified by the appearance of loco-regional treatments as well as the introduction of immunotherapy that have shown their efficacy in the control of ICC. The aim of this review is to describe the current status of treatments for ICCs, as well as the different therapeutic strategies being assessed.(c) 2023 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:346 / 355
页数:10
相关论文
共 50 条
  • [1] Intrahepatic cholangiocarcinoma: current perspectives
    Buettner, Stefan
    van Vugt, Jeroen L. A.
    Ijzermans, Jan N. M.
    Koerkamp, Bas Groot
    ONCOTARGETS AND THERAPY, 2017, 10 : 1131 - 1142
  • [2] Current status of intrahepatic cholangiocarcinoma
    Jian Yang
    World Journal of Gastroenterology, 2008, (41) : 6289 - 6297
  • [3] Current status of intrahepatic cholangiocarcinoma
    Yang, Jian
    Yan, Lu-Nan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (41) : 6289 - 6297
  • [4] Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma
    Hewitt, D. Brock
    Brown, Zachary J.
    Pawlik, Timothy M.
    CANCERS, 2022, 14 (09)
  • [5] Surgical management of intrahepatic cholangiocarcinoma
    Ruff, Samantha M.
    Pawlik, Timothy M.
    HEPATOMA RESEARCH, 2023, 9
  • [6] Surgical management of intrahepatic cholangiocarcinoma
    Hewitt, D. Brock
    Brown, Zachary J.
    Pawlik, Timothy M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (01) : 27 - 38
  • [7] Surgical management of intrahepatic cholangiocarcinoma
    Lieser, MJ
    Barry, MK
    Rowland, C
    Ilstrup, DM
    Nagorney, DM
    HEPATOLOGY, 1997, 26 (04) : 204 - 204
  • [8] Intrahepatic cholangiocarcinoma: Limitations for resectability, current surgical concepts and future perspectives
    Machairas, Nikolaos
    Lang, Hauke
    Jayant, Kumar
    Raptis, Dimitri A.
    Sotiropoulos, Georgios C.
    EJSO, 2020, 46 (05): : 740 - 746
  • [9] Challenges of surgical management of intrahepatic cholangiocarcinoma
    Squires, Malcolm H.
    Cloyd, Jordan M.
    Dillhoff, Mary
    Schmidt, Carl
    Pawlik, Timothy M.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (07) : 671 - 681
  • [10] Intrahepatic cholangiocarcinoma - current perspectives and treatment algorithm
    Lurje, G.
    Bednarsch, J.
    Roderburg, C.
    Trautwein, C.
    Neumann, U. P.
    CHIRURG, 2018, 89 (11): : 858 - 864